Montes Archimedes Acquisition (ROIV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Brepocitinib 30 mg improved the Total Improvement Score to 46.5 vs 31.2 for placebo at week 52. 42% of brepocitinib patients stopped steroids completely vs 23% for placebo by the end of the study. Up Next: Wall Street trader's 34-0 strategy goes public this week. See it first →
U.S. stocks were mixed, with the Dow Jones index gaining more than 200 points on Wednesday. Shares of Lyft, Inc. LYFT rose sharply during Wednesday's session after the company and Waymo announced plans to expand to Nashville next year, with Lyft's Flexdrive managing Waymo's fully autonomous ...